Private equity firm buys CIVCO Radiotherapy
October 22, 2021 -- Private equity firm Blue Wolf Capital Partners is acquiring CIVCO Radiotherapy from Roper Technologies, the firm announced. Read More
RaySearch, Mevion team up for Flash delivery treatment planning
October 22, 2021 -- RaySearch Laboratories and Mevion Medical Systems are collaborating to develop advanced treatment planning techniques for delivery of Flash radiation therapy with the Mevion S250i proton therapy system. Read More
RefleXion to showcase tech, abstracts at ASTRO 2021
October 22, 2021 -- RefleXion Medical will showcase multiple clinical abstracts and its technology at the American Society for Radiation Oncology (ASTRO) 2021 annual meeting, October 24-27, in Chicago. Read More
Accuray reports revenue gains for Q1
October 22, 2021 -- Accuray reported gains in its preliminary financial results for the first quarter of the 2022 fiscal year, with the company citing an increase in gross orders as a growth driver. Read More
IBA launches Campus online proton therapy platform
October 20, 2021 -- Proton therapy developer Ion Beam Applications (IBA) has launched Campus, an online proton therapy platform. Read More
Varian highlights new offerings at ASTRO 2021
October 19, 2021 -- Radiation oncology vendor Varian is emphasizing the benefits of its combination with Siemens Healthineers, as well as several new products, at the annual meeting of the American Society for Radiation Oncology (ASTRO), held October 24-27. Read More
ITM secures supply deal with Clovis Oncology
October 19, 2021 -- German radiopharmaceutical firm ITM Isotope Technologies Munich has signed an agreement to supply its EndolucinBeta no-carrier-added lutetium-177 radiopharmaceutical precursor to Clovis Oncology. Read More
Accuray to introduce Volo Ultra at ASTRO 2021
October 19, 2021 -- Radiation oncology firm Accuray plans to feature its Volo Ultra planning upgrade at the annual meeting of the American Society for Radiation Oncology (ASTRO), which is being held October 24-27. Read More
Varian's Embozene microspheres receive 'breakthrough' designation
October 14, 2021 -- Varian has received a breakthrough device designation from the U.S. Food and Drug Administration for its Embozene microspheres for genicular artery embolization for symptomatic knee osteoarthritis. Read More
ARTMS seeks nod from Health Canada for Ga-68 production
October 14, 2021 -- ARTMS has submitted a drug master file to the Health Products and Food Branch of Health Canada for the production of gallium-68 (Ga-68). Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT